Clinical trial on terapeutic efficacy, tolerability and safety of peroral solutions Varumin® 1 and 2 (INTER-EVROGENEKS) in a combined treatment with polyvitamin - antioxidative therapy in patitnts with biologicaly (PCR) detected HPV infections of high-risc type, with od without biopticaly verified CIN I
Varumin® is new hope for all MULTIPLE SCLEROSIS (MS) patients.
One small, but still significant study made some time ago, undoubtedly has proven that immuno-modulatory effect of Varumin® acts hepful in treatment of this ilness.
"Inter-evrogeneks" goes on with promotion of the first product ever, which managed complete elimination of presence of all signs characteristical for MS.
Expert's report: Expert Sibin Ilic, PhD, MD, for Varumin®?